Keywords: vivus, shares, tumble, muse, concerns, become, latest

Vivus Shares Tumble On MUSE Concerns

Article | 03 March 1997

Print This

Vivus has become the latest biopharmaceutical company to suffer from ayo-yoing share price. The company's shares climbed to over $80 after ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in